​

Roivant Sciences (ROIV) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Roivant Sciences Revenue Highlights

Latest Revenue (Y)

$124.80M

Latest Revenue (Q)

$1.57M

Main Segment (Y)

Product

Roivant Sciences Revenue by Period

Roivant Sciences Revenue by Year

DateRevenueChange
2024-03-31$124.80M103.65%
2023-03-31$61.28M10.84%
2022-03-31$55.29M132.34%
2021-03-31$23.80M-64.85%
2020-03-31$67.69M-

Roivant Sciences generated $124.80M in revenue during NA 2023, up 103.65% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Roivant Sciences Revenue by Quarter

DateRevenueChange
2025-09-30$1.57M-27.60%
2025-06-30$2.17M-71.33%
2025-03-31$7.57M-16.06%
2024-12-31$9.02M101.52%
2024-09-30$4.47M-43.99%
2024-06-30$7.99M-72.38%
2024-03-31$28.93M85.90%
2023-12-31$15.56M326.59%
2023-09-30$3.65M-83.13%
2023-06-30$21.62M-21.01%
2023-03-31$27.38M60.54%
2022-12-31$17.05M21.91%
2021-09-30$13.99M80.83%
2021-06-30$7.74M-48.93%
2021-03-31$15.15M163.41%
2020-12-31$5.75M334.62%
2020-09-30$1.32M-16.05%
2020-06-30$1.58M-97.50%
2020-03-31$62.95M-

Roivant Sciences generated $1.57M in revenue during Q2 2025, up -27.60% compared to the previous quarter, and up 19.66% compared to the same period a year ago.

Roivant Sciences Revenue Breakdown

Roivant Sciences Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceMar 24Mar 23
Product$75.06M$28.01M

Roivant Sciences's latest annual revenue breakdown by segment (product or service), as of Mar 24: Product (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 24Dec 23Sep 23Jun 23
Product Revenue, Net$18.37M$20.67M$18.42M$16.66M

Roivant Sciences's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product Revenue, Net (100.00%).

Roivant Sciences Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
JAZZJazz Pharmaceuticals$4.07B$1.05B
MRNAModerna$3.24B$1.02B
EXASExact Sciences$2.76B$850.74M
RPRXRoyalty Pharma$2.26B$609.29M
IONSIonis Pharmaceuticals$705.14M$156.72M
ASNDAscendis Pharma$266.72M$95.89M
BBIOBridgeBio Pharma$221.90M$108.11M
ROIVRoivant Sciences$124.80M$1.57M
RNAAvidity Biosciences$10.90M$12.47M
RVMDRevolution Medicines--
SMMTSummit Therapeutics--

ROIV Revenue FAQ

What is Roivant Sciences’s yearly revenue?

Roivant Sciences's yearly revenue for 2023 was $124.8M, representing an increase of 103.65% compared to 2022. The company's yearly revenue for 2022 was $61.28M, representing an increase of 10.84% compared to 2021. ROIV's yearly revenue for 2021 was $55.29M, representing an increase of 132.34% compared to 2020.

What is Roivant Sciences’s quarterly revenue?

Roivant Sciences's quarterly revenue for Q2 2025 was $1.57M, a -27.60% decrease from the previous quarter (Q1 2025), and a -64.89% decrease year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $2.17M, a -71.33% decrease from the previous quarter (Q4 2024), and a -72.84% decrease year-over-year (Q1 2024). ROIV's quarterly revenue for Q4 2024 was $7.57M, a -16.06% decrease from the previous quarter (Q3 2024), and a -73.83% decrease year-over-year (Q4 2023).

What is Roivant Sciences’s revenue growth rate?

Roivant Sciences's revenue growth rate for the last 3 years (2021-2023) was 125.73%, and for the last 5 years (2019-2023) was 84.37%.

What are Roivant Sciences’s revenue streams?

Roivant Sciences's revenue streams in r 24 are Product

What is Roivant Sciences’s main source of revenue?

For the fiscal year ending Mar 24, the largest source of revenue of Roivant Sciences was Product. This segment made a revenue of $75.06M, representing 100.00% of the company's total revenue.